UTERINE LEIOMYOSARCOMA
Clinical trials for UTERINE LEIOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UTERINE LEIOMYOSARCOMA trials appear
Sign up with your email to follow new studies for UTERINE LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a breast cancer drug help fight a rare uterine cancer?
Disease control Recruiting nowThis study tests if letrozole, a daily pill, can delay cancer growth in people newly diagnosed with uterine leiomyosarcoma that hasn't spread. About 40 participants will either take letrozole or be watched without treatment. The goal is to see if the drug extends the time before …
Matched conditions: UTERINE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: GOG Foundation • Aim: Disease control
Last updated May 17, 2026 07:37 UTC
-
Can chemo after surgery stop uterine cancer's return? new trial seeks answers.
Disease control Recruiting nowThis study tests whether giving standard chemotherapy (doxorubicin and trabectedin) after surgery can help people with early-stage uterine leiomyosarcoma stay cancer-free longer. About 48 adults who had their tumor fully removed will receive the drugs and be monitored for side ef…
Matched conditions: UTERINE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New drug targets Hormone-Fueled uterine sarcomas
Disease control Recruiting nowThis study tests a drug called elacestrant in people with advanced uterine sarcomas that are fueled by estrogen. The drug works by blocking and breaking down estrogen receptors on cancer cells. About 30 participants will receive the drug to see if it can shrink tumors and control…
Matched conditions: UTERINE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 12, 2026 13:42 UTC